# Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer

> **NCT02973217** · NA · COMPLETED · sponsor: **Clinical Laserthermia Systems AB** · enrollment: 5 (actual)

## Conditions studied

- Neoplasms Pancreatic

## Interventions

- **DEVICE:** Immunostimulating Interstitial Laser Thermotherapy

## Key facts

- **NCT ID:** NCT02973217
- **Lead sponsor:** Clinical Laserthermia Systems AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2019-04-29
- **Final completion:** 2019-07-22
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2020-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02973217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02973217, "Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02973217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*